{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:17:26Z","timestamp":1790338646303,"version":"4.1.0"},"reference-count":65,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T00:00:00Z","timestamp":1537920000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NWO-TTW","award":["15380"],"award-info":[{"award-number":["15380"]}]},{"name":"Horizon 2020 MSCA grant","award":["675743"],"award-info":[{"award-number":["675743"]}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Primary cytomegalovirus (CMV) infection leads to strong innate and adaptive immune responses against the virus, which prevents serious disease. However, CMV infection can cause serious morbidity and mortality in individuals who are immunocompromised. The adaptive immune response to CMV is characterized by large populations of effector-memory (EM) T cells that are maintained lifelong, a process termed memory inflation. Recent findings indicate that infection with CMV leads to continuous differentiation of CMV-specific EM-like T cells and that high-dose infection accelerates this progression. Whether measures that counteract CMV infection, such as anti-viral drugs, targeting of latently infected cells, adoptive transfer of CMV-specific T cells, and vaccination strategies, are able to impact the progressive differentiation of CMV-specific EM-like cells is discussed.<\/ns4:p>","DOI":"10.12688\/f1000research.15753.1","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T06:10:05Z","timestamp":1537942205000},"page":"1554","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Cytomegalovirus infection and progressive differentiation of effector-memory T cells"],"prefix":"10.12688","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1642-1857","authenticated-orcid":false,"given":"Iris N.","family":"Pardieck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9044-3486","authenticated-orcid":false,"given":"Guillaume","family":"Beyrend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Redeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5058-4110","authenticated-orcid":false,"given":"Ramon","family":"Arens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2018,9,26]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"202-13","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection.","volume":"20","author":"M Cannon","year":"2010","journal-title":"Rev Med Virol."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"288-97","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus.","volume":"235","author":"P Griffiths","year":"2015","journal-title":"J Pathol."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"954-7","DOI":"10.1002\/eji.201570044","article-title":"5th International Workshop on CMV and Immunosenescence - A shadow of cytomegalovirus infection on immunological memory.","volume":"45","author":"R Arens","year":"2015","journal-title":"Eur J Immunol."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"54-62","DOI":"10.1016\/j.exger.2014.03.020","article-title":"New advances in CMV and immunosenescence.","volume":"55","author":"P Sansoni","year":"2014","journal-title":"Exp Gerontol."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"3881-9","DOI":"10.4049\/jimmunol.1800171","article-title":"Cytomegalovirus: Shape-Shifting the Immune System.","volume":"200","author":"G Picarda","year":"2018","journal-title":"J Immunol."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"673-85","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.","volume":"202","author":"A Sylwester","year":"2005","journal-title":"J Exp Med."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"37-47","DOI":"10.1016\/j.cell.2014.12.020","article-title":"Variation in the human immune system is largely driven by non-heritable influences.","volume":"160","author":"P Brodin","year":"2015","journal-title":"Cell."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"217-43","DOI":"10.1016\/B978-0-12-396548-6.00009-3","article-title":"Rational design of vaccines: learning from immune evasion mechanisms of persistent viruses and tumors.","volume":"114","author":"R Arens","year":"2012","journal-title":"Adv Immunol."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"333-59","DOI":"10.1007\/978-3-540-77349-8_19","article-title":"Cytomegalovirus immune evasion.","volume":"325","author":"C Powers","year":"2008","journal-title":"Curr Top Microbiol Immunol."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"390-6","DOI":"10.1128\/JVI.01839-10","article-title":"B7-mediated costimulation of CD4 T cells constrains cytomegalovirus persistence.","volume":"85","author":"R Arens","year":"2011","journal-title":"J Virol."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"2913-21","DOI":"10.1182\/blood.V99.8.2913","article-title":"Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells.","volume":"99","author":"M Moutaftsi","year":"2002","journal-title":"Blood."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"2022-9","DOI":"10.4049\/jimmunol.170.4.2022","article-title":"Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.","volume":"170","author":"U Karrer","year":"2003","journal-title":"J Immunol."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"84-90","DOI":"10.1016\/j.it.2011.11.005","article-title":"Memory T cell inflation: understanding cause and effect.","volume":"33","author":"G O'Hara","year":"2012","journal-title":"Trends Immunol."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"99-112","DOI":"10.1111\/imr.12653","article-title":"The (gradual) rise of memory inflation.","volume":"283","author":"P Klenerman","year":"2018","journal-title":"Immunol Rev."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"1046-57","DOI":"10.1002\/eji.201343946","article-title":"Viral inoculum dose impacts memory T-cell inflation.","volume":"44","author":"A Redeker","year":"2014","journal-title":"Eur J Immunol."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"450-8","DOI":"10.4049\/jimmunol.177.1.450","article-title":"Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection.","volume":"177","author":"M Munks","year":"2006","journal-title":"J Immunol."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"650-9","DOI":"10.1016\/j.immuni.2008.07.017","article-title":"Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells.","volume":"29","author":"C Snyder","year":"2008","journal-title":"Immunity."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"4077-90","DOI":"10.1172\/JCI42758","article-title":"Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation.","volume":"120","author":"K Hertoghs","year":"2010","journal-title":"J Clin Invest."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"161-75","DOI":"10.1111\/imr.12649","article-title":"Memory CD8 T cell inflation vs tissue-resident memory T cells: Same patrollers, same controllers?","volume":"283","author":"S Welten","year":"2018","journal-title":"Immunol Rev."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"79-89","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: Local specialists in immune defence.","volume":"16","author":"S Mueller","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"4792-801","DOI":"10.4049\/jimmunol.1501083","article-title":"The Quantity of Autocrine IL-2 Governs the Expansion Potential of CD8+ T Cells.","volume":"195","author":"A Redeker","year":"2015","journal-title":"J Immunol."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"739-48","DOI":"10.1109\/TVCG.2017.2744318","article-title":"CyteGuide: Visual Guidance for Hierarchical Single-Cell Analysis.","volume":"24","author":"T Hollt","year":"2018","journal-title":"IEEE Trans Vis Comput Graph."},{"key":"ref-23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01689-9","article-title":"Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types.","volume":"8","author":"V van Unen","year":"2017","journal-title":"Nat Commun."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3389\/fimmu.2017.01953","article-title":"The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious Dose.","volume":"8","author":"A Redeker","year":"2017","journal-title":"Front Immunol."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"6851-65","DOI":"10.1128\/JVI.03305-12","article-title":"CD27-CD70 costimulation controls T cell immunity during acute and persistent cytomegalovirus infection.","volume":"87","author":"S Welten","year":"2013","journal-title":"J Virol."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"1726-36","DOI":"10.4049\/jimmunol.1402757","article-title":"Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.","volume":"194","author":"M Quinn","year":"2015","journal-title":"J Immunol."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"e1002313","DOI":"10.1371\/journal.ppat.1002313","article-title":"Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection.","volume":"7","author":"N Torti","year":"2011","journal-title":"PLoS Pathog."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"e1006993","DOI":"10.1371\/journal.ppat.1006993","article-title":"Tissue maintenance of CMV-specific inflationary memory T cells by IL-15.","volume":"14","author":"N Baumann","year":"2018","journal-title":"PLoS Pathog."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"1502-12","DOI":"10.1002\/eji.200637023","article-title":"Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.","volume":"37","author":"M Bachmann","year":"2007","journal-title":"Eur J Immunol."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"1557-60","DOI":"10.1002\/jmv.23642","article-title":"Impact of human cytomegalovirus (CMV) infection on immune response to pandemic 2009 H1N1 influenza vaccine in healthy adults.","volume":"85","author":"A Wald","year":"2013","journal-title":"J Med Virol."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"287-97","DOI":"10.1007\/s11357-013-9557-4","article-title":"Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults.","volume":"36","author":"J Turner","year":"2014","journal-title":"Age (Dordr)."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"3826-36","DOI":"10.1016\/S0264-410X(03)00309-8","article-title":"Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence.","volume":"21","author":"P Trzonkowski","year":"2003","journal-title":"Vaccine."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fimmu.2018.00082","article-title":"Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults.","volume":"9","author":"S van den Berg","year":"2018","journal-title":"Front Immunol."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"4869-74","DOI":"10.1016\/j.vaccine.2011.03.086","article-title":"Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities.","volume":"29","author":"W den Elzen","year":"2011","journal-title":"Vaccine."},{"key":"ref-35","doi-asserted-by":"publisher","first-page":"281ra43","DOI":"10.1126\/scitranslmed.aaa2293","article-title":"Cytomegalovirus infection enhances the immune response to influenza.","volume":"7","author":"D Furman","year":"2015","journal-title":"Sci Transl Med."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"436-42","DOI":"10.3109\/23744235.2015.1135252","article-title":"Humoral response to influenza vaccination in relation to pre-vaccination antibody titres, vaccination history, cytomegalovirus serostatus and CD4\/CD8 ratio.","volume":"48","author":"J Strindhall","year":"2016","journal-title":"Infect Dis (Lond)."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"e1002850","DOI":"10.1371\/journal.ppat.1002850","article-title":"Immune senescence: relative contributions of age and cytomegalovirus infection.","volume":"8","author":"A Mekker","year":"2012","journal-title":"PLoS Pathog."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"e1002849","DOI":"10.1371\/journal.ppat.1002849","article-title":"Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging.","volume":"8","author":"L Cicin-Sain","year":"2012","journal-title":"PLoS Pathog."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"E6817-E6825","DOI":"10.1073\/pnas.1719451115","article-title":"Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection.","volume":"115","author":"M Smithey","year":"2018","journal-title":"Proc Natl Acad Sci U S A."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"326-9","DOI":"10.1038\/nature05762","article-title":"Herpesvirus latency confers symbiotic protection from bacterial infection.","volume":"447","author":"E Barton","year":"2007","journal-title":"Nature."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"e0167097","DOI":"10.1371\/journal.pone.0167097","article-title":"Cytomegalovirus Reinfections Stimulate CD8 T-Memory Inflation.","volume":"11","author":"J Trgovcich","year":"2016","journal-title":"PLoS One."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"475-503","DOI":"10.2174\/187152611797636640","article-title":"Antiviral treatment of cytomegalovirus infection.","volume":"11","author":"A Ahmed","year":"2011","journal-title":"Infect Disord Drug Targets."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"585-96","DOI":"10.1080\/17474086.2016.1174571","article-title":"Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation.","volume":"9","author":"E Maffini","year":"2016","journal-title":"Expert Rev Hematol."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"779-89","DOI":"10.1128\/JVI.02427-12","article-title":"Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection.","volume":"87","author":"M Beswick","year":"2013","journal-title":"J Virol."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"293-9","DOI":"10.1097\/QCO.0000000000000170","article-title":"Approach to drug-resistant cytomegalovirus in transplant recipients.","volume":"28","author":"S Chou","year":"2015","journal-title":"Curr Opin Infect Dis."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"128-38","DOI":"10.1038\/cmi.2014.75","article-title":"The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?","volume":"12","author":"M Wills","year":"2015","journal-title":"Cell Mol Immunol."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"199-202","DOI":"10.1126\/science.1235047","article-title":"Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection.","volume":"340","author":"M Weekes","year":"2013","journal-title":"Science."},{"key":"ref-48","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01754-17","article-title":"Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.","volume":"8","author":"B Krishna","year":"2017","journal-title":"mBio."},{"key":"ref-49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14321","article-title":"Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.","volume":"8","author":"B Krishna","year":"2017","journal-title":"Nat Commun."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"594-606","DOI":"10.1016\/j.celrep.2018.06.048","article-title":"A Virally Encoded DeSUMOylase Activity Is Required for Cytomegalovirus Reactivation from Latency.","volume":"24","author":"E Poole","year":"2018","journal-title":"Cell Rep."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/cti.2015.5","article-title":"Adoptive T-cell immunotherapy for ganciclovir-resistant CMV disease after lung transplantation.","volume":"4","author":"C Holmes-Liew","year":"2015","journal-title":"Clin Transl Immunology."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"293-8","DOI":"10.1097\/CJI.0b013e31824300a2","article-title":"Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections.","volume":"35","author":"L Bao","year":"2012","journal-title":"J Immunother."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3389\/fimmu.2016.00352","article-title":"CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies.","volume":"7","author":"C Smith","year":"2016","journal-title":"Front Immunol."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"49-57","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.","volume":"52","author":"K Peggs","year":"2011","journal-title":"Clin Infect Dis."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"5071-80","DOI":"10.1182\/blood-2009-04-214684","article-title":"The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor.","volume":"114","author":"P Scheinberg","year":"2009","journal-title":"Blood."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"294-305","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.","volume":"118","author":"C Berger","year":"2008","journal-title":"J Clin Invest."},{"key":"ref-57","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00268-17","article-title":"Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.","volume":"24","author":"M Schleiss","year":"2017","journal-title":"Clin Vaccine Immunol."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"13-23","DOI":"10.1016\/j.coviro.2014.02.004","article-title":"Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease.","volume":"6","author":"D Wang","year":"2014","journal-title":"Curr Opin Virol."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"2763-71","DOI":"10.1080\/21645515.2017.1308988","article-title":"Functionally inactivated dominant viral antigens of human cytomegalovirus delivered in replication incompetent adenovirus type 6 vectors as vaccine candidates.","volume":"13","author":"A Tang","year":"2017","journal-title":"Hum Vaccin Immunother."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"1689-99","DOI":"10.1016\/j.vaccine.2018.01.029","article-title":"Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.","volume":"36","author":"S John","year":"2018","journal-title":"Vaccine."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"7766-75","DOI":"10.1128\/JVI.00633-07","article-title":"DNA immunization using highly conserved murine cytomegalovirus genes encoding homologs of human cytomegalovirus UL54 (DNA polymerase) and UL105 (helicase) elicits strong CD8 T-cell responses and is protective against systemic challenge.","volume":"81","author":"C Morello","year":"2007","journal-title":"J Virol."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"1968-74","DOI":"10.1002\/jmv.23688","article-title":"An attenuated temperature-sensitive strain of cytomegalovirus (tsm5) establishes immunity without development of CD8+ T cell memory inflation.","volume":"85","author":"M Beswick","year":"2013","journal-title":"J Med Virol."},{"key":"ref-63","doi-asserted-by":"publisher","first-page":"e1002295","DOI":"10.1371\/journal.ppat.1002295","article-title":"Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus.","volume":"7","author":"C Snyder","year":"2011","journal-title":"PLoS Pathog."},{"key":"ref-64","doi-asserted-by":"publisher","first-page":"e1005895","DOI":"10.1371\/journal.ppat.1005895","article-title":"The Breadth of Synthetic Long Peptide Vaccine-Induced CD8+ T Cell Responses Determines the Efficacy against Mouse Cytomegalovirus Infection.","volume":"12","author":"E Panagioti","year":"2016","journal-title":"PLoS Pathog."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fimmu.2017.00144","article-title":"Enforced OX40 Stimulation Empowers Booster Vaccines to Induce Effective CD4+ and CD8+ T Cell Responses against Mouse Cytomegalovirus Infection.","volume":"8","author":"E Panagioti","year":"2017","journal-title":"Front Immunol."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/7-1554\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1554\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/7-1554\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T15:30:59Z","timestamp":1553873459000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/7-1554\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,26]]},"references-count":65,"URL":"https:\/\/doi.org\/10.12688\/f1000research.15753.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.17195.r38582","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.17195.r38583","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.17195.r38581","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,26]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/7-1554\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.17195.r38583, Christopher Snyder, Department of Immunology and Microbiology, Thomas Jefferson University, Philadelphia, PA, USA, 26 Sep 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1554\/v1#referee-response-38583","order":0,"name":"referee-response-38583","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.17195.r38581, Ian Humphreys, Division of Infection Immunity, School of Medicine\/Systems Immunity University Research Institute, Cardiff University, Cardiff, UK, 26 Sep 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1554\/v1#referee-response-38581","order":1,"name":"referee-response-38581","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.17195.r38582, Paul Moss, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK, 26 Sep 2018, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/7-1554\/v1#referee-response-38582","order":2,"name":"referee-response-38582","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was funded by a grant from NWO-TTW (project 15380, awarded to RA) and by a Horizon 2020 MSCA grant (project 675743, acronym ISPIC) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}